I have talked to colleagues in anesthesiology from Britain, Australia, New Zealand—some of them are a little outside of the G-7, I realize. They do not have the problems we have or our American colleagues seem to have had. They smiled and said they had a little bit of a blip two years ago and it was addressed by their central agencies.
It hasn't been a problem. They seem to source a lot of their medications in Asia and get them there. The Brits just don't seem to have a problem.